DuPont Raises 2026 Outlook Again as Q3 Adjusted EPS Jumps 62.0% to $2.09
DuPont raised its full-year 2026 outlook again on Tuesday after third-quarter adjusted earnings per share jumped 62.0% to $2.09, beating its own guidance on organic growth and productivity gains.
The materials maker now expects 2026 adjusted EPS of $7.47 to $7.52 and organic sales growth of an estimated 4.5%, according to the earnings release it filed with an 8-K. It projects full-year net sales of an estimated $7.19 billion and operating EBITDA of an estimated $1.785 billion, the company said. Chief Financial Officer Antonella Franzen said the targets are all at or above the high end of previously communicated guidance.
Third-quarter net sales rose 4.1% to $1.87 billion from $1.80 billion, with organic sales up 5% and a 1% currency headwind. Income from continuing operations climbed 67.6% to $171 million, and GAAP EPS from continuing operations rose 77.1% to $1.24 from $0.70.
"We delivered another quarter of consistent, high-quality performance, once again exceeding our financial guidance," CEO Lori Koch said in the release.
Both segments grow
Healthcare & Water Technologies net sales increased 4.0% to $865 million, with operating EBITDA up 6.9% to $263 million and the margin widening to 30.4% from 29.6%. DuPont cited growth in personal protection and medical packaging, plus industrial water, semiconductor and specialty markets, partially offset by continued disruptions in the Middle East.
Diversified Industrials net sales grew 4.2% to $1.00 billion, and operating EBITDA rose 10.5% to $242 million for a 24.1% margin, up from 22.7%. Building Technologies grew in North America and Asia, while Industrial Technologies benefited from aerospace and electric vehicle battery applications.
Total operating EBITDA increased 7.6% to $469 million, lifting the margin to 25.1% from 24.3%.
Cash and buybacks
Cash provided by operating activities from continuing operations rose 27.3% to $410 million. Transaction-adjusted free cash flow was $341 million, representing 121% conversion.
DuPont completed a $250 million accelerated share repurchase and substantially completed $100 million of open market repurchases in the third quarter. It said it intends to repurchase another $250 million of shares in the fourth quarter.
Fourth-quarter guide
For the fourth quarter, DuPont guided adjusted EPS to $1.90 to $1.95 on net sales of an estimated $1.825 billion and operating EBITDA of an estimated $455 million, the company said.
Per-share figures reflect DuPont's 1-for-3 reverse stock split, which took effect June 24, 2026, and results are presented on a continuing operations basis after the April 1 sale of its Aramids business.
By the numbers
- Net sales: $1.87 billion, up 4.1%
- GAAP EPS from continuing operations: $1.24, up 77.1%
- Adjusted EPS: $2.09, up 62.0%
- Operating EBITDA: $469 million, up 7.6%
- 2026 adjusted EPS outlook: $7.47 to $7.52, raised
- Planned fourth-quarter buyback: $250 million
Sources
- DuPont de Nemours Form 8-K with third-quarter 2026 earnings release, filed Nov. 3, 2026 (accession 0001666700-26-000058)
This article is for informational and educational purposes only and is not investment advice. It is not a recommendation to buy or sell any security.
Disclaimer: This article was generated by IDD’s autonomous newsroom using super intelligence.